Journals / Uluslararası Hematoloji-Onkoloji Dergisi / 2009 / Cilt: 19 - Sayı: 2

Akut myeloblastik lösemili bir hastada FLAG-IDA rejimi ile ilişkili fetal ölüm

Fetal loss in a patient with acute myeloblastic leukemia associated with FLAG-IDA regime

Pages
110–112
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Understanding the role of drug transporters in moderating transplacental passage of substrates has important clinical implications for choosing specific drugs to achieve therapeutic objectives.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Acute leukemia in pregnancy offers a unique management dilemma in the absence of clear guidelines.
📊
Key Findings & Data:There is some transporters localized into the placental trophoblasts plays an important role in limiting the passage of substrate drug.
💡
Conclusion & Impact:Understanding the role of drug transporters in moderating transplacental passage of substrates has important clinical implications for choosing specific drugs to achieve therapeutic objectives.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Kadın · Fetüs ölümü · Lösemi

Abstract

Acute leukemia in pregnancy offers a unique management dilemma in the absence of clear guidelines. There is some transporters localized into the placental trophoblasts plays an important role in limiting the passage of substrate drug. Herein, we reported a case of fetal loss in a pregnant patient in 34 gestational weeks, with acute myeloblastic leukemia who treated with high dose cytarabine plus fludarabine chemotherapy, to discuss the effects of cytotoxic agent on fetus. There were many reports about pregnancies complicated with AML treated with standart dose cytosine arabinoside and antracyclin combination. We suggest that high dose chemotherapy, mainly FLAG-IDA regime may cause fetal death, although in nearby term periods. Understanding the role of drug transporters in moderating transplacental passage of substrates has important clinical implications for choosing specific drugs to achieve therapeutic objectives.

Özet

Gebelikte ve lösemi tedavisi, açık kılavuzların olmaması nedeni ile oldukça büyük bir çıkmazdır. Plasental trofoblastlarda lokalize bazı transporterler ilaç ve ürünleri için önemli bariyerlerdir. Biz bu yazımızda 34 haftalık gebeliği olan akut myeloblastik lösemi hastasında, yüksek doz sitozin arabinozid ve fludarabin kemoterapisi sonrası oluşan bir gebelik kaybı vakasını sunmayı ve sitotoksik ilaçların fetüs üzerine etkilerini tartışmayı amaçladık. Akut lösemi tanısı almış birçok gebede standart doz sitozin-arabinozid ve antrasiklinin kullanımına dair çok sayıda vaka tarif edilmiştir. Yüksek doz kemoterapinin, özellikle de FLAG-IDA rejiminin terme yaklaşmış gebelikte bile ölüme neden olabildiğini gördük. İlaç transporterlerinin rollerini araştırmaya yönelik çalışmalar pratikte ilaç seçimi ve gebe hastayı bekleyen riskleri daha iyi öngörmeyi sağlayabilir.

🔖

Cite This Article

PAŞA, S., ALTINTAŞ, A., ÇİL, T., AYYILDIZ, O. (2009). Akut myeloblastik lösemili bir hastada FLAG-IDA rejimi ile ilişkili fetal ölüm. Uluslararası Hematoloji-Onkoloji Dergisi, Cilt: 19 - Sayı: 2, 110–112. https://ajindex.com/articles/322971

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (5)

  1. Ali R, Ozkalemkas F, Ozcelik T, et al. Maternal and fetal outcomes in pregnancy complicated with acute leukemia: a single institutional experience with 10 pregnancies at 16 years. Leuk Res 27: 381-385, 2003
  2. Ganapathy V, Prasad PD, Ganapathy ME, et al. Placental Transporters Relevant to Drug Distribution across the Maternal-Fetal Interface. J Pharmacol Exp Ther 294: 413-420, 2000
  3. Wang JS, Newport DJ, Stowe ZN, et al. The Emerging Importance of Transporter Proteins in the Psychopharmacological Treatment of the Pregnant Patient. Drug Metab Rev 39: 723-746, 2007
  4. Reynoso EE, Shepherd FA, Messner HA, et al. Acute Leukemia During Pregnancy: The Toronto Leukemia Study Group Experience With Long-Term Follow-Up of Children Exposed In Utero to Chemotherapeutic Agents. J Clin Oncol 5: 1098-1106, 1987
  5. Feliu J, Juarez S, Ordonez A, et al. Acute Leukemia and Pregnancy. Cancer 61: 580-584, 1988.